121 related articles for article (PubMed ID: 9058210)
1. Hemoglobin-based oxygen carriers: problems and promise.
Tremper KK
J Cardiothorac Vasc Anesth; 1997 Feb; 11(1):1-2. PubMed ID: 9058210
[No Abstract] [Full Text] [Related]
2. Are newer generation hemoglobin-based oxygen carriers safe: do they offer an answer?
Jahr JS
Vascul Pharmacol; 2010; 52(5-6):214. PubMed ID: 20060496
[No Abstract] [Full Text] [Related]
3. S-nitrosylated polyethylene glycol-conjugated hemoglobin derivative as a candidate material for oxygen therapeutics.
Nakai K; Sakuma I; Togashi H; Yoshioka M; Sugawara T; Satoh H; Kitabatake A
Adv Exp Med Biol; 2003; 519():207-16. PubMed ID: 12675217
[No Abstract] [Full Text] [Related]
4. Performances of PEG-modified hemoglobin-vesicles as artificial oxygen carriers in microcirculation.
Sakai H; Tsuchida E
Clin Hemorheol Microcirc; 2006; 34(1-2):335-40. PubMed ID: 16543654
[TBL] [Abstract][Full Text] [Related]
5. Liposome-encapsulated hemoglobin as a red cell surrogate. Preparation scale-up.
Beissinger RL; Farmer MC; Gossage JL
ASAIO Trans; 1986; 32(1):58-63. PubMed ID: 3778774
[No Abstract] [Full Text] [Related]
6. Hemoglobin preparations for perfusion & infusion problems of large-scale production.
Bonhard K
Biomater Artif Cells Artif Organs; 1988; 16(1-3):85-91. PubMed ID: 3179497
[No Abstract] [Full Text] [Related]
7. Hemoglobin-based oxygen carriers: disclosed history and the way ahead: the relativity of safety.
Weiskopf RB
Anesth Analg; 2014 Oct; 119(4):758-760. PubMed ID: 25232689
[No Abstract] [Full Text] [Related]
8. Artificial Oxygen Carriers: Exactly How Close Are We to an Ultimate Product?
Simoni J
Artif Organs; 2017 Apr; 41(4):316-318. PubMed ID: 28397406
[No Abstract] [Full Text] [Related]
9. [Current development of the problem of "artificial blood"].
Ivanov KP
Gematol Transfuziol; 1992 Feb; 37(2):26-9. PubMed ID: 1426905
[No Abstract] [Full Text] [Related]
10. Hemoglobin-based oxygen carriers: first, second or third generation? Human or bovine? Where are we now?
Napolitano LM
Crit Care Clin; 2009 Apr; 25(2):279-301, Table of Contents. PubMed ID: 19341909
[TBL] [Abstract][Full Text] [Related]
11. Isovolemic hemodilution with a bovine hemoglobin-based oxygen carrier: effects on hemodynamics and oxygen transport in comparison with a nonoxygen-carrying volume substitute.
Krieter H; Hagen G; Waschke KF; Köhler A; Wenneis B; Brückner UB; van Ackern K
J Cardiothorac Vasc Anesth; 1997 Feb; 11(1):3-9. PubMed ID: 9058211
[TBL] [Abstract][Full Text] [Related]
12. Hemoglobin solutions as blood substitutes.
Friedman HI; Devenuto F; Kerwin A; Carson K; Bynoe R
J Invest Surg; 2000; 13(2):79-94. PubMed ID: 10801045
[No Abstract] [Full Text] [Related]
13. Submicron biodegradable polymer membrane hemoglobin nanocapsules as potential blood substitutes: a preliminary report.
Yu WP; Chang TM
Artif Cells Blood Substit Immobil Biotechnol; 1994; 22(3):889-93. PubMed ID: 7994414
[TBL] [Abstract][Full Text] [Related]
14. Hemoglobin tetramers stabilized with polyaspirins.
Bucci E; Fronticelli C; Razynska A; Militello V; Koehler R; Urbaitis B
Biomater Artif Cells Immobilization Biotechnol; 1992; 20(2-4):243-52. PubMed ID: 1391438
[TBL] [Abstract][Full Text] [Related]
15. Proposition of a technique to assess the vasoactive effects of hemoglobin-based oxygen carrying solutions in vivo: preliminary results in the rabbit aorta.
Caron A; Menu P; Labrude P; Vigneron C
Artif Cells Blood Substit Immobil Biotechnol; 1998 May; 26(3):293-308. PubMed ID: 9635122
[TBL] [Abstract][Full Text] [Related]
16. Artificial Oxygen Carrier as Therapeutics Rather Than Blood Substitute for Transfusion.
Kawaguchi AT
Artif Organs; 2017 Apr; 41(4):312-315. PubMed ID: 28397405
[No Abstract] [Full Text] [Related]
17. Submicron polymer membrane hemoglobin nanocapsules as potential blood substitutes: preparation and characterization.
Yu WP; Chang TM
Artif Cells Blood Substit Immobil Biotechnol; 1996 May; 24(3):169-83. PubMed ID: 8773737
[TBL] [Abstract][Full Text] [Related]
18. [Liposome-encapsulated hemoglobin ameliorates brain dysfunction after transient cerebral ischemia in rats].
Yamaguchi T; Hamadate N; Sugawara A; Togashi H; Yamamoto T; Yoshioka M
Nihon Shinkei Seishin Yakurigaku Zasshi; 2012 Apr; 32(2):97-9. PubMed ID: 22708265
[No Abstract] [Full Text] [Related]
19. Development of zero-link polymers of hemoglobin, which do not extravasate and do not induce pressure increases upon infusion.
Bucci E; Kwansa H; Koehler RC; Matheson B
Artif Cells Blood Substit Immobil Biotechnol; 2007; 35(1):11-8. PubMed ID: 17364467
[TBL] [Abstract][Full Text] [Related]
20. Microvascular responses to hemodilution with Hb vesicles as red blood cell substitutes: influence of O2 affinity.
Sakai H; Tsai AG; Rohlfs RJ; Hara H; Takeoka S; Tsuchida E; Intaglietta M
Am J Physiol; 1999 Feb; 276(2):H553-62. PubMed ID: 9950857
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
